Publications by authors named "Capone Mariaelena"

Claim this Profile
D
Development of an innovative duplex digital PCR assay for circulating MiRNA ratio quantification in metastatic melanoma.
Alex De Gregorio, Andrea Sacconi, Chiara Mandoj, Fabio Valenti, Valentina De Pascale, Mariaelena Capone

J Transl Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inherited mitochondrial genetics as a predictor of immune checkpoint inhibition efficacy in melanoma.
Kelsey R Monson, Robert Ferguson, Joanna E Handzlik, Leah Morales, Jiahan Xiong, Mariaelena Capone

Nat Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene-expression signature predicts autoimmune toxicity in metastatic melanoma.
Domenico Mallardo, Mario Fordellone, Michael Bailey, Andrew White, Ester Simeone, Mariaelena Capone

J Immunother Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-related changes in lactate dehydrogenase A expression differently impact the immune response in melanoma.
Marta Iozzo, Giuseppina Comito, Luigi Ippolito, Giada Sandrini, Elisa Pardella, Mariaelena Capone

FEBS J· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolomic signatures in liquid biopsy are associated with overall survival in metastatic melanoma patients treated with immune checkpoint inhibitor therapy.
Susan Costantini, Gabriele Madonna, Mariaelena Capone, Elena Di Gennaro, Palmina Bagnara

J Exp Clin Cancer Res· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of the androgen receptor in melanoma aggressiveness.
Marzia Di Donato, Costanza Maria Cristiani, Mariaelena Capone, Cinzia Garofalo, Gabriele Madonna

Cell Death Dis· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal analysis of the gut microbiota during anti-PD-1 therapy reveals stable microbial features of response in melanoma patients.
Angeli D G Macandog, Carlotta Catozzi, Mariaelena Capone, Amir Nabinejad, Padma P Nanaware

Cell Host Microbe· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ICOSLG Is Associated with Anti-PD-1 and Concomitant Antihistamine Treatment Response in Advanced Melanoma.
Domenico Mallardo, Mario Fordellone, Margaret Ottaviano, Giuseppina Marano, Maria Grazia Vitale, Mariaelena Capone

Int J Mol Sci· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of SLC22A17 DNA methylation hotspot as a potential biomarker in cutaneous melanoma.
Alessandro Lavoro, Luca Falzone, Giuseppe Gattuso, Giuseppe N Conti, Rosario Caltabiano, Mariaelena Capone

J Transl Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innate Immune Cells in Melanoma: Implications for Immunotherapy.
Marialuisa Trocchia, Annagioia Ventrici, Luca Modestino, Leonardo Cristinziano, Anne Lise Ferrara, Mariaelena Capone

Int J Mol Sci· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methylation‑sensitive restriction enzyme‑droplet digital PCR assay for the one‑step highly sensitive analysis of DNA methylation hotspots.
Giuseppe Gattuso, Alessandro Lavoro, Rosario Caltabiano, Gabriele Madonna, Mariaelena Capone

Int J Mol Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort study.
Xue Bai, Ahmed Shaheen, Charlotte Grieco, Paolo D d'Arienzo, Florentia Mina, Mariaelena Capone

EClinicalMedicine· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Prognostic Model for Early Breast Cancer Integrating Neutrophil to Lymphocyte Ratio and Clinical-Pathological Characteristics.
Sara Socorro Faria, Diana Giannarelli, Vladmir Claudio Cordeiro de Lima, Sumadi Luckman Anwar, Chiara Casadei, Mariaelena Capone

Oncologist· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The MITF/mir-579-3p regulatory axis dictates BRAF-mutated melanoma cell fate in response to MAPK inhibitors.
Domenico Liguoro, Rachele Frigerio, Arianna Ortolano, Andrea Sacconi, Mario Acunzo, Mariaelena Capone

Cell Death Dis· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort study.
Xue Bai, Ahmed Shaheen, Charlotte Grieco, Paolo D d'Arienzo, Florentia Mina, Mariaelena Capone

EClinicalMedicine· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upregulated expression of miR-4443 and miR-4488 in drug resistant melanomas promotes migratory and invasive phenotypes through downregulation of intermediate filament nestin.
Vittorio Castaldo, Michele Minopoli, Francesca Di Modugno, Andrea Sacconi, Domenico Liguoro, Mariaelena Capone

J Exp Clin Cancer Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melanoma-derived soluble mediators modulate neutrophil biological properties and the release of neutrophil extracellular traps.
Luca Modestino, Leonardo Cristinziano, Marialuisa Trocchia, Annagioia Ventrici, Mariaelena Capone

Cancer Immunol Immunother· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline immunomodulatory expression quantitative trait loci (ieQTLs) associated with immune-related toxicity from checkpoint inhibition.
Robert Ferguson, Vylyny Chat, Leah Morales, Danny Simpson, Kelsey R Monson, Mariaelena Capone

Eur J Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential clinical implications of CD4CD26 T cells for nivolumab treated melanoma patients.
Domenico Galati, Serena Zanotta, Mariaelena Capone, Gabriele Madonna, Domenico Mallardo

J Transl Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Insights into the Identification of Metabolites and Cytokines Predictive of Outcome for Patients with Severe SARS-CoV-2 Infection Showed Similarity with Cancer.
Susan Costantini, Gabriele Madonna, Elena Di Gennaro, Francesca Capone, Palmina Bagnara, Mariaelena Capone

Int J Mol Sci· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors.
Nicolas Gonzalo Nuñez, Fiamma Berner, Ekaterina Friebel, Susanne Unger, Nina Wyss, Mariaelena Capone

Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab.
Domenico Mallardo, Ester Simeone, Lucia Festino, Marilena Tuffanelli, Vito Vanella, Mariaelena Capone

J Transl Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant plus adjuvant combined or sequenced vemurafenib, cobimetinib and atezolizumab in patients with high-risk, resectable BRAF-mutated and wild-type melanoma: NEO-TIM, a phase II randomized non-comparative study.
Paolo A Ascierto, Eleonora Cioli, Vanna Chiarion-Sileni, Pietro Quaglino, Francesco Spagnolo, Mariaelena Capone

Front Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a miRNA-based non-invasive predictive biomarker of response to target therapy in BRAF-mutant melanoma.
Ciro Francesco Ruggiero, Luigi Fattore, Irene Terrenato, Francesca Sperati, Valentina Salvati, Mariaelena Capone

Theranostics· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the MITF/APAF-1 axis as salvage therapy for MAPK inhibitors in resistant melanoma.
Pietro Carotenuto, Alessia Romano, Anna Barbato, Paola Quadrano, Simona Brillante, Mariaelena Capone

Cell Rep· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis